SESSION II: MYELODYSPLASTIC SYNDROMES

Session Chairs: Guillermo Garcia-Manero, MD and Valeria Santini, MD

Molecular and Cellular Basis of MDS | Jaroslaw Maciejewski, MD, PhD | Cleveland Clinic, Cleveland, Ohio, USA

Therapeutic Advances in Lower Risk MDS | Valeria Santini, MD | University of Florence, Florence, Italy

Higher Risk MDS in 2025 | Amy E. DeZern, MD, MHS | Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Transplantation for Myelodysplastic Syndromes | Uday R. Popat, MD | MD Anderson Cancer Center, Houston, Texas, USA

AI Approaches in MDS | Matteo Della Porta, MD | Humanitas Research Hospital, Milan, Italy

Oral Abstract TBA | Speaker | Affiliation, City, State, Country